Mackenzie Financial’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.27M | Buy |
189,408
+35,203
| +23% | +$1.35M | 0.01% | 534 |
|
2025
Q1 | $5.97M | Buy |
+154,205
| New | +$5.97M | 0.01% | 543 |
|
2018
Q4 | – | Sell |
-22,037
| Closed | -$1.11M | – | 1174 |
|
2018
Q3 | $1.11M | Sell |
22,037
-104
| -0.5% | -$5.22K | ﹤0.01% | 741 |
|
2018
Q2 | $1.12M | Buy |
22,141
+8,895
| +67% | +$448K | ﹤0.01% | 668 |
|
2018
Q1 | $647K | Buy |
13,246
+2,092
| +19% | +$102K | ﹤0.01% | 693 |
|
2017
Q4 | $495K | Buy |
11,154
+3,165
| +40% | +$140K | ﹤0.01% | 687 |
|
2017
Q3 | $405K | Buy |
7,989
+460
| +6% | +$23.3K | ﹤0.01% | 535 |
|
2017
Q2 | $406K | Buy |
7,529
+3,689
| +96% | +$199K | ﹤0.01% | 534 |
|
2017
Q1 | $202K | Buy |
+3,840
| New | +$202K | ﹤0.01% | 604 |
|